Research on epidemiological clinical practice survey of Castleman disease

Research on epidemiological clinical practice survey of Castleman disease - Research on epidemiological clinical practice survey of Castleman disease

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000035088

Enrollment

300

Registered

2018-12-12

Start date

2018-12-12

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Castleman disease

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: A case diagnosed as Castleman Disease. Hyaline vascular type, plasma cell type and intermediate type. Plasma cell type can be HHV 8 positive or negative.

Exclusion criteria

Exclusion criteria: A case that the doctor judged inappropriate.

Design outcomes

Primary

Measure	Time frame
Clinical data, multi-suspension array of serum / plasma, serum antibody array, microarray, immunocomplex LC-MS / MS, flow cytometry, biopsy tissue array	—

Countries

Japan,North America

Contacts

Public ContactYoshizaki Kazuyuki

Institute of Scientific and Industrial Research Department of Biomolecular Science and Regulation, The

kyoshi@sanken.osaka-u.ac.jp06-6877-5737

Outcome results